env Chimeric Virus Technology for Evaluating Human Immunodeficiency Virus Susceptibility to Entry Inhibitors

We describe the development of chimeric virus technology (CVT) for human immunodeficiency virus (HIV) type 1 (HIV-1) env genes gp120, gp41, and gp160 for evaluation of the susceptibilities of HIV to entry inhibitors. This env CVT allows the recombination of env sequences derived from different strai...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Fikkert, Valery, Cherepanov, Peter, Van Laethem, Kristel, Hantson, Anke, Van Remoortel, Barbara, Pannecouque, Christophe, De Clercq, Erik, Debyser, Zeger, Vandamme, Anne-Mieke, Witvrouw, Myriam
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2002
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC132780/
https://ncbi.nlm.nih.gov/pubmed/12435701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.12.3954-3962.2002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi